TITAN PHARMACEUTICALS INC 4
4 · TITAN PHARMACEUTICALS INC · Filed Feb 2, 2016
Insider Transaction Report
Form 4
BHONSLE SUNIL
DirectorPresident
Transactions
- Award
Option to Purchase Common Stock
2016-02-02+89,100→ 89,100 totalExercise: $5.10Exp: 2026-02-02→ Common Stock (89,100 underlying)
Footnotes (1)
- [F1]The options vest in 24 equal monthly installments commencing on the grant date.